News
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
908 Devices to Participate in Upcoming Investor Conferences
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
908 Devices to Participate in Upcoming Investor Conferences
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
email Subscribe to Our Communications Signup to receive new product updates, technical tips and more.